IL84917A - Quinolinone derivative,its preparation and pharmaceutical compositions containing it - Google Patents

Quinolinone derivative,its preparation and pharmaceutical compositions containing it

Info

Publication number
IL84917A
IL84917A IL84917A IL8491787A IL84917A IL 84917 A IL84917 A IL 84917A IL 84917 A IL84917 A IL 84917A IL 8491787 A IL8491787 A IL 8491787A IL 84917 A IL84917 A IL 84917A
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
quinolinone derivative
quinolinone
Prior art date
Application number
IL84917A
Other languages
English (en)
Other versions
IL84917A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL84917A0 publication Critical patent/IL84917A0/xx
Publication of IL84917A publication Critical patent/IL84917A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Secondary Cells (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL84917A 1986-12-23 1987-12-22 Quinolinone derivative,its preparation and pharmaceutical compositions containing it IL84917A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630702A GB8630702D0 (en) 1986-12-23 1986-12-23 Quinoline compound

Publications (2)

Publication Number Publication Date
IL84917A0 IL84917A0 (en) 1988-06-30
IL84917A true IL84917A (en) 1991-08-16

Family

ID=10609475

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84917A IL84917A (en) 1986-12-23 1987-12-22 Quinolinone derivative,its preparation and pharmaceutical compositions containing it

Country Status (22)

Country Link
US (1) US4937248A (da)
EP (1) EP0272910B1 (da)
JP (1) JPS63166866A (da)
KR (1) KR880007514A (da)
AT (1) ATE65993T1 (da)
AU (1) AU594220B2 (da)
CA (1) CA1318671C (da)
DE (1) DE3772015D1 (da)
DK (1) DK163429C (da)
ES (1) ES2029842T3 (da)
FI (1) FI90768C (da)
GB (1) GB8630702D0 (da)
GR (1) GR3002445T3 (da)
HU (1) HU196991B (da)
IE (1) IE60619B1 (da)
IL (1) IL84917A (da)
MX (1) MX9203788A (da)
MY (1) MY102277A (da)
NZ (1) NZ223036A (da)
PH (1) PH23448A (da)
PT (1) PT86448B (da)
ZA (1) ZA879615B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166160A (en) * 1986-12-23 1992-11-24 Burroughs Wellcome Co. Quinoline compound
GB8820174D0 (en) * 1988-08-25 1988-09-28 Wellcome Found Quinoline compound
CA2304849A1 (en) * 1997-09-24 1999-04-01 Orion Corporation Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors
MXPA02002032A (es) 1999-08-27 2003-05-19 Ligand Pharm Inc Compuestos moduladores del receptor de androgeno y metodos.
EP1212322A2 (en) 1999-08-27 2002-06-12 Ligand Pharmaceuticals Incorporated 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
US6593493B1 (en) 1999-09-14 2003-07-15 Ligand Pharmaceuticals, Inc. RXR modulators with improved pharmacologic profile
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
BRPI0413820A (pt) 2003-08-22 2006-10-24 Ligand Pharm Inc derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
CA2920856C (en) 2013-08-09 2026-03-03 Ardelyx, Inc. Ph modulating compounds for inhibiting gastrointestinal phosphate uptake
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2616855A (en) * 1948-01-15 1952-11-04 Procter & Gamble Detergent composition
US4329347A (en) * 1978-02-17 1982-05-11 Boehringer Ingelheim Gmbh Cardiotonic and antithrombotic sulfur-containing derivatives of carbostyril
JPS5777676A (en) * 1980-10-31 1982-05-15 Otsuka Pharmaceut Co Ltd Carbostyril derivative
US4710507A (en) * 1983-12-22 1987-12-01 Pfizer Inc. Quinolone inotropic agents
PT80533B (en) * 1984-05-29 1987-04-06 Pfizer Process for preparing quinolone inotropic agents
US4760064A (en) * 1984-12-18 1988-07-26 Otsuka Pharmaceutical Co., Ltd. Carbostyril compounds, compositions containing same and processes for preparing same
US4845100A (en) * 1985-04-12 1989-07-04 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, processes for preparing the same and cardiotonic composition containing the same
FR2580646A1 (fr) * 1985-04-19 1986-10-24 Synthelabo Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
DK111387A (da) * 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
EP0255134B1 (en) * 1986-07-31 1993-03-03 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives and salts thereof, process for preparing them, and cardiotonic composition containing same

Also Published As

Publication number Publication date
FI90768B (fi) 1993-12-15
FI875666L (fi) 1988-06-24
DK680887D0 (da) 1987-12-22
FI90768C (fi) 1994-03-25
ES2029842T3 (es) 1992-10-01
ZA879615B (en) 1989-08-30
EP0272910A1 (en) 1988-06-29
PT86448B (pt) 1990-11-20
PH23448A (en) 1989-08-07
GB8630702D0 (en) 1987-02-04
DK163429B (da) 1992-03-02
AU8293387A (en) 1988-06-23
AU594220B2 (en) 1990-03-01
CA1318671C (en) 1993-06-01
DK163429C (da) 1992-07-20
ATE65993T1 (de) 1991-08-15
DE3772015D1 (de) 1991-09-12
KR880007514A (ko) 1988-08-27
US4937248A (en) 1990-06-26
EP0272910B1 (en) 1991-08-07
NZ223036A (en) 1990-11-27
GR3002445T3 (en) 1992-12-30
FI875666A0 (fi) 1987-12-22
JPS63166866A (ja) 1988-07-11
MY102277A (en) 1992-05-15
IE60619B1 (en) 1994-07-27
HUT45984A (en) 1988-09-28
IE873490L (en) 1988-06-23
MX9203788A (es) 1992-07-01
HU196991B (en) 1989-02-28
IL84917A0 (en) 1988-06-30
DK680887A (da) 1988-06-24
PT86448A (en) 1988-01-01

Similar Documents

Publication Publication Date Title
IL84917A0 (en) Quinolinone derivative,its preparation and pharmaceutical compositions containing it
PT88603A (pt) Immunomodulatory azapiranes
KR870700620A (ko) 신규 약리학적 화합물
FI885594A0 (fi) Tiazolidindioner anvaendbara foer saenkande av blodsockerhalten samt atherosklerosis hindrande medel.
GR3004139T3 (da)
IL99829A0 (en) Heteroaroyl derivatives of monocyclic beta-lactams,pharmaceutical compositions containing the same and processes for the preparation thereof
AU7987587A (en) Quinoline base compound, process for the preparation thereof and anticancer agent containing the same as pharmacologically efficacious component
KR880007070A (ko) 백내장 치료용 약학 조성물
GB8820174D0 (en) Quinoline compound
EP0399626A3 (en) Substituted tetrahydroisoquinoline compounds, their production, and pharmaceutical compositions containing them
GR3007498T3 (da)
ATE74604T1 (de) Substituierte pyrimidochinoxaline.
GR3001003T3 (en) Novel pregnane derivatives, processes for their preparaton and pharmaceutical compositions containing same
EP0154491A3 (en) Quinate salts of the antimalarial compound mefloquine
AU8292787A (en) Fluorine-containing macrolide compounds and their use

Legal Events

Date Code Title Description
RH Patent void